Clinical Trials Directory

Trials / Completed

CompletedNCT02064205

Appetite Suppression Trial With Polydextrose

A Double Blind, Placebo Controlled, Randomized, Cross-over Study to Assess the Effects of Polydextrose on Appetite Suppression and Its Mechanisms of Action in Healthy Women With a Normal Weight and Overweight Female Participants.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
W.J. Pasman · Academic / Other
Sex
Female
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

Overweight and obesity are a global epidemic, which causes a rapid increase in the frequency of diabetes and cardiovascular diseases. Food ingredients that influence the mechanisms that regulate satiety may play a role in weight management. Suppression of appetite may reduce energy intake, which in return may lead to body weight reduction. This study aims to verify the appetite suppressive effect of polydextrose in comparison to a placebo in normal weight and overweight women.

Detailed description

Polydextrose is a well-tolerated, low calorie glucose polymer (4kJ/g) that can be easily incorporated into various food applications to replace sugar and fat (Auerbach et al., 2007). Polydextrose is poorly digested in the upper gastrointestinal tract and therefore shows fiber-like properties. The addition of polydextrose to foods may increase the satiating properties of foods. Previous studies have shown that: * Consuming polydextrose-containing preloads (6.25 - 25.0 g polydextrose) resulted in a significant lower energy intake at lunch compared to the control (Astbury et al., 2013; Ranawana et al., 2013; Hull et al., 2012; King et al., 2005). * Polydextrose is able to modify appetite ratings at low (6.25 - 12.5 g polydextrose) (Hull et al., 2012) and high doses (56.7 g/d) (Konings et al., 2013). * Polydextrose (15.0 g) induced enhanced GLP-1 response after a high-fat meal in obese participants (Tiihonen et al., 2012). Therefore, it is hypothesized that with the consumption of 12.5 g polydextrose as compared with the placebo, appetite will be suppressed, resulting in: * a lower consumption at lunch (energy intake at lunch) * change in appetite scores (VAS) * change in satiety hormones (CCK, PYY, GLP-1, ghrelin) * change in glucose and insulin * change in stomach emptying rate * change in gastric wellbeing

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT12.5 g polydextroseAppetite suppressing supplement is added in yogurt and provided with breakfast (four hours before lunch) or 1.5h before lunch. Also yogurt with control (glucose syrup) is tested for its satiating effect.
DIETARY_SUPPLEMENTglucose syrupGlucose syrup is used a control product for the polydextrose

Timeline

Start date
2014-05-01
Primary completion
2014-10-01
Completion
2014-12-01
First posted
2014-02-17
Last updated
2022-06-06
Results posted
2016-07-27

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02064205. Inclusion in this directory is not an endorsement.